Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum. ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
Breast Cancer (Expert Forum)
New drug for Breast Cancer
Questions posted in the Breast Cancer Forum are answered by medical professionals from The Cleveland Clinic. Topics include Breast Biopsy, Chemotherapy, Hormone Therapy, Lumps, Lumpectomy, Lymph node dissection, Lymphedema, Mammograms, Mastectomy, Radiation Therapy, Reconstruction, Self Breast Exam, and Surgery.
New drug for Breast Cancer
by Redbean, Dec 11, 2001 12:00AM
I heard on the Today Show that there is a new drug that has been shown to be very effective in early stage breast cancer even more effective than Tamoxafen. could you please tell me the name of this drug and when it might be available. They were saying that this drug has less toxicity than tamoxafen. Thank you.
Doctor's Answer
by CCF-RN,MSN-JS, Dec 11, 2001 12:00AM
Dear Redbean, The drug you may be referring to is raloxifen hydrochloride (Evista). It is one of the family of medications called SERMs (Selective Estrogen Receptor Modulators) of which tamoxifen is also part of. Raloxifen has been FDA approved for use as prevention of osteoporosis in postmenopausal women. In evaluating raloxifene overall evidence showed that it was reducing the risk of invasive breast cancers in postmenopausal women. There is currently a large trial being conducted comparing raloxifene with tamoxifen in terms of breast cancer prevention, this trial is commonly referred to as the STAR trial (Study of Tamoxifen and Raloxifene). Studies continue as to role of raloxifene in adjuvant treatment of early stage cancers.
The most common side effects of raloxifene are hot flashes and leg cramps. There is an increased risk of development of deep vein thrombosis, however there was not shown to be an increase risk of endometrial cancer that has been noted with tamoxifen use.
The most common side effects of raloxifene are hot flashes and leg cramps. There is an increased risk of development of deep vein thrombosis, however there was not shown to be an increase risk of endometrial cancer that has been noted with tamoxifen use.
Letrozole(Femara), made by Novartis Pharmaceuticals Corporation, is in a class of drugs called aromatase inhibitors. Aromatase is a protein that converts male-type hormones into the common female hormone estrogen.
In 1997, Femara was approved as a treatment to be used if tamoxifen failed. But if the panel's recommendations are followed, Femara could take the lead as the preferred first treatment.